Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yasuo Miyoshi

Showing results (111-120 of 178) with videos related to

Pageof 18
Sort By:
Breast Cancer (Tokyo, Japan)|March 7, 2021
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in JapanMasato Takahashi, Kenichi Inoue, Hirofumi Mukai, et al.
Anesthesiology and Pain Medicine|September 26, 2018
C-reactive Protein Level on Postoperative Day One is Associated with Chronic Postsurgical Pain After MastectomyKazuma Hashimoto, Ayano Tsuji, Shiho Takenaka, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)Takahiro Nakayama, Yasuaki Sagara, Tsutomu Takashima, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2018
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in JapanKazuhiro Kitajima, Koya Nakatani, Kazushige Yamaguchi, et al.
Scientific Reports|May 14, 2017
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeuticsTetsuro Yoshimaru, Keisuke Aihara, Masato Komatsu, et al.
Breast Cancer (Tokyo, Japan)|March 12, 2015
Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011Junichi Kurebayashi, Yasuo Miyoshi, Takashi Ishikawa, et al.
Breast Cancer (Tokyo, Japan)|March 7, 2024
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in JapanYasue Tsuchida, Naoki Niikura, Takashi Chishima, et al.
Plos One|June 9, 2015
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer CellsNam-Hee Kim, Tetsuro Yoshimaru, Yi-An Chen, et al.
Clinical Breast Cancer|January 21, 2015
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast CancerArisa Nishimukai, Tomoko Yagi, Ayako Yanai, et al.
Breast Cancer Research and Treatment|February 5, 2005
Usefulness of three-dimensional multidetector-row CT images for preoperative evaluation of tumor extension in primary breast cancer patientsTomoo Inoue, Yasuhiro Tamaki, Seiki Hamada, et al.
Pageof 18

Showing results (111-120 of 178) with videos related to

Sort By:
Pageof 18
Breast Cancer (Tokyo, Japan)|March 7, 2021
Indices of peripheral leukocytes predict longer overall survival in breast cancer patients on eribulin in JapanMasato Takahashi, Kenichi Inoue, Hirofumi Mukai, et al.
Anesthesiology and Pain Medicine|September 26, 2018
C-reactive Protein Level on Postoperative Day One is Associated with Chronic Postsurgical Pain After MastectomyKazuma Hashimoto, Ayano Tsuji, Shiho Takenaka, et al.
Cancer Chemotherapy and Pharmacology|February 23, 2018
Randomized phase II study of anastrozole plus tegafur-uracil as neoadjuvant therapy for ER-positive breast cancer in postmenopausal Japanese women (Neo-ACET BC)Takahiro Nakayama, Yasuaki Sagara, Tsutomu Takashima, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 14, 2018
Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST - multicenter study in JapanKazuhiro Kitajima, Koya Nakatani, Kazushige Yamaguchi, et al.
Scientific Reports|May 14, 2017
Stapled BIG3 helical peptide ERAP potentiates anti-tumour activity for breast cancer therapeuticsTetsuro Yoshimaru, Keisuke Aihara, Masato Komatsu, et al.
Breast Cancer (Tokyo, Japan)|March 12, 2015
Clinicopathological characteristics of breast cancer and trends in the management of breast cancer patients in Japan: Based on the Breast Cancer Registry of the Japanese Breast Cancer Society between 2004 and 2011Junichi Kurebayashi, Yasuo Miyoshi, Takashi Ishikawa, et al.
Breast Cancer (Tokyo, Japan)|March 7, 2024
Correlation between postoperative treatment selection and prognosis determined using the Oncotype DX® test data: a retrospective multicenter study in JapanYasue Tsuchida, Naoki Niikura, Takashi Chishima, et al.
Plos One|June 9, 2015
BIG3 Inhibits the Estrogen-Dependent Nuclear Translocation of PHB2 via Multiple Karyopherin-Alpha Proteins in Breast Cancer CellsNam-Hee Kim, Tetsuro Yoshimaru, Yi-An Chen, et al.
Clinical Breast Cancer|January 21, 2015
High Ki-67 Expression and Low Progesterone Receptor Expression Could Independently Lead to a Worse Prognosis for Postmenopausal Patients With Estrogen Receptor-Positive and HER2-Negative Breast CancerArisa Nishimukai, Tomoko Yagi, Ayako Yanai, et al.
Breast Cancer Research and Treatment|February 5, 2005
Usefulness of three-dimensional multidetector-row CT images for preoperative evaluation of tumor extension in primary breast cancer patientsTomoo Inoue, Yasuhiro Tamaki, Seiki Hamada, et al.
Pageof 18